09/11 2023 Regulatory Interim Report Q3 – January – September, 2023 Redsense Medical AB (publ) JULY – SEPTEMBER 2023 · Net sales amounted to kSEK 5,287 (1,023), an increase of 417%. · Operating loss, EBIT amounted to kSEK 959 (5,857). … [read more]
26/10 2023 Regulatory Nomination Committee appointed for the 2024 Annual General Meeting of Redsense Medical AB A Nomination Committee has been established for the 2024 Annual General Meeting of Redsense Medical AB. The Nomination Committee, which has been appointed in accordance… [read more]
05/10 2023 Non-regulatory Redsense Medical to present at the Small Cap Growth Virtual Investor Conference Redsense Medical AB will present live at the Small Cap Growth Virtual Investor Conference, hosted by VirtualInvestorConferences.com, on October 12, 2023. CEO Pontus Nobréus will… [read more]
